Gabapentin decreases the severity of dystonia at low doses in a genetic animal model of paroxysmal dystonic choreoathetosis

Author： Richter A.   Loscher W.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.369, Iss.3, 1999-03, pp. : 335-338

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of pharmacological manipulations of cannabinoid receptors on severity of dystonia in a genetic model of paroxysmal dyskinesia

By Richter A.   Loscher W.  

European Journal of Pharmacology, Vol. 454, Iss. 2, 2002-11 ,pp. : 145-151

Elsevier

Access to resources Recommend Favorite

Lower KV7.5 Potassium Channel Subunit Expression in an Animal Model of Paroxysmal Dystonia

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 15, Iss. 1, 2016-02 ,pp. : 95-101

Bentham Science Publishers

Access to resources Recommend Favorite

Paradoxical aggravation of paroxysmal dystonia during chronic treatment with phenobarbital in a genetic rodent model

By Richter A.   Loscher W.  

European Journal of Pharmacology, Vol. 397, Iss. 2, 2000-06 ,pp. : 343-350

Elsevier

Access to resources Recommend Favorite

The kynurenine 3-hydroxylase inhibitor Ro 61-8048 improves dystonia in a genetic model of paroxysmal dyskinesia

By Richter A.   Hamann M.  

European Journal of Pharmacology, Vol. 478, Iss. 1, 2003-09 ,pp. : 47-52

Elsevier

Access to resources Recommend Favorite

Antimyoclonic effect of gabapentin in a posthypoxic animal model of myoclonus

By Kanthasamy A.G.   Vu T.Q.   Yun R.J.   Truong D.D.  

European Journal of Pharmacology, Vol. 297, Iss. 3, 1996-02 ,pp. : 219-224

Elsevier

Access to resources Recommend Favorite